| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.0069 | 0.9 |